The introduction of readily available exome sequencing into rare disease clinics will lead to the recognition of additional patients with milder variants of DBP deficiency and will improve our understanding of the phenotypic spectrum and natural history of this and other diseases. The gene discussed is DBP; the disease is hyperinsulinemic hypoglycemia, familial, 4.